ThinkSono key facts
as of Oct 2026- Developer of an automatic point-of-care diagnostic system designed to diagnose deep vein thrombosis.
- ThinkSono is valued at approximately $34.5M as of Oct 2026 (last reported valuation).
- It has raised $12.9M; the latest was Later Stage VC ($6.2M) in Jun 2025.
- Notable investors include Entrepreneurs First, Tech Nation Group, Speedinvest, Tiny Supercomputer Investment Company, MMC Ventures — 26 tracked in total.
- Status: Privately Held (backing).
ThinkSono's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch ThinkSono: the Monday email on marks, rounds and moves
ThinkSono funding rounds
No funding rounds for ThinkSono are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs ThinkSono
26+ThinkSono valuation
ThinkSono's last reported valuation was $34.5 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
ThinkSono investors
26 investors are on record for ThinkSono, including Entrepreneurs First, Tech Nation Group, Speedinvest and Tiny Supercomputer Investment Company.
About ThinkSono
Developer of an automatic point-of-care diagnostic system designed to diagnose deep vein thrombosis. The company's system uses deep learning technologies to instruct the healthcare professional to place the probe on the skin where underlying vessels are expected and acquire the ultrasound images for subsequent analysis, enabling doctors to diagnose deep vein thrombosis in ten minutes at the point of care.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 3
- Website
- thinksono.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.